文献速递睡眠呼吸障碍

持续气道正压通气对阵发性房颤合并睡眠呼吸暂停患者心律失常的影响:一项随机对照试验

Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

本研究为开放标签、平行组随机对照试验,纳入阵发性房颤合并中重度睡眠呼吸暂停(AHI≥15)患者,随机接受CPAP联合常规治疗5个月(n=55)或单纯常规治疗(n=54)。主要结局为植入式循环记录仪测量的房颤负荷变化,结果显示CPAP组与对照组调整后组间差异为-0.63个百分点(95%CI -2.55至1.30,P=0.52),无统计学显著性。

要点

  • 阵发性房颤合并中重度睡眠呼吸暂停患者中,CPAP治疗5个月未显著降低房颤负荷。
  • CPAP组严重不良事件7例(13%),对照组2例(4%)。
  • 研究人群筛选过程中仅42%的阵发性房颤患者存在中重度睡眠呼吸暂停。

核心结论

  • 在阵发性房颤合并睡眠呼吸暂停患者中,CPAP治疗未导致房颤负荷的统计学显著降低。

研究设计与样本

  • 开放标签、平行组随机对照试验,纳入阵发性房颤合并中重度睡眠呼吸暂停(AHI≥15)患者。
  • 随机1:1接受CPAP联合常规治疗5个月(CPAP组n=55)或单纯常规治疗(对照组n=54)。
  • 结局评估采用盲法,主要结局为植入式循环记录仪测量的房颤负荷(房颤时间百分比)变化。

主要发现

  • CPAP组房颤平均时间从基线5.6%降至干预最后3个月的4.1%,对照组从5.0%降至4.3%。
  • 随访时调整后组间差异为-0.63个百分点(95%CI -2.55至1.30,P=0.52)。
  • CPAP组发生7例严重不良事件(13%),对照组发生2例(4%)。

关键数值与推荐

  • 中重度睡眠呼吸暂停定义为呼吸暂停低通气指数(AHI)≥15。
  • 主要结局为房颤负荷变化,调整后组间差异-0.63个百分点(95%CI -2.55至1.30,P=0.52)。

临床怎么用

  • 对于阵发性房颤合并中重度睡眠呼吸暂停患者,CPAP治疗5个月未显著减少房颤负荷。
  • 临床决策需综合考虑CPAP对睡眠呼吸暂停本身的获益及其他心血管结局。

局限性

  • 开放标签设计,但结局评估采用盲法。
  • 筛查579例阵发性房颤患者中仅244例(42%)存在中重度睡眠呼吸暂停,最终仅108例纳入主要分析。
  • CPAP run-in期158例中39例(25%)未耐受治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Sleep apnea (SA) is highly prevalent in patients with atrial fibrillation (AF), and both conditions are associated with adverse cardiovascular outcomes.Objectives: To determine the effect of continuous positive airway pressure (CPAP) on AF burden.Methods: This open-label, parallel-group, randomized controlled trial included patients with paroxysmal AF and moderate to severe SA (apnea-hypopnea index ⩾15). A computerized system randomized eligible patients (1:1) to 5 months' treatment with CPAP plus usual care (CPAP, n = 55) or usual care alone (control, n = 54). The outcome assessment was blinded. The planned primary outcome was the difference between CPAP treatment and control groups in change of AF burden (percentage of time in AF) as measured by implantable loop recorder.Measurements and Main Results: A total of 579 patients with paroxysmal AF had respiratory polygraphy, of whom 244 (42%) had moderate to severe SA. Of these, 158 (65%) participated in the CPAP run-in period, of whom 39 (25%) patients did not tolerate the treatment. A total of 108 patients were available for the primary analysis. The mean time in AF decreased from 5.6% at baseline to 4.1% during the last 3 months of CPAP intervention and from 5.0% to 4.3% in the control group. The adjusted between-group difference at follow-up was -0.63 (95% confidence interval, -2.55 to 1.30) percentage points (P = 0.52). Seven serious adverse events (13%) occurred in the CPAP group, and two (4%) occurred in the control group.Conclusions: In patients with paroxysmal AF and SA, treatment with CPAP did not result in a statistically significant reduction in the burden of AF.Clinical trial registered with www.clinicaltrials.gov (NCT02727192).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Traaen GM, Aakerøy L, Hunt TE, et al. Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial. Am J Respir Crit Care Med. 2021. PMID: 33938787. doi:10.1164/rccm.202011-4133OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。